Webinars
Register for upcoming webinars and watch recordings of past events. Interested in putting on your own live webinar? Talk to us.
LIVE WEBINAR | AUGUST 27 | 1PM - 2PM ET
Real-world data offers powerful opportunities to study disease progression, treatment safety and effectiveness, and patient outcomes—but some of the most clinically meaningful details are buried in unstructured sources like clinical notes and diagnostic reports
Real-world data offers powerful opportunities to study disease progression, treatment safety and effectiveness, and patient outcomes—but some of the most clinically meaningful details are buried in unstructured sources like clinical notes and diagnostic reports
With venture funding tightening in the post-COVID landscape, efficiency has
become more critical than ever. In this interactive webinar industry experts
explored actionable strategies for maintaining quality under financial
pressure. Watch now.
Are long R&D cycles, overwhelming literature reviews, or patent
bottlenecks slowing your path to innovation? In the fast-evolving life
science landscape, AI is no longer a luxury, it’s a necessity.
BioSpace’s NextGen companies are rising in one of the most
confounding biotech markets ever experienced. Executives sounded off on how
to keep your head above water during our webinar, Are We There Yet?
BioSpace sits down with four NextGen companies that are thriving despite a
multi-year down period. You will hear about ways they are defying the odds
to churn out clinical data that may finally provide the industry with a
ladder out. Watch now.
In this discussion, our guests explore how recent regulatory changes are
shaping the future of AI in drug development in the US market. Watch
now.
This webinar will help you discover effective strategies for launching your
career in biotechnology. You will gain valuable insights from industry
experts and leave with the essential tools you need to thrive in this
dynamic field.
This webinar explores the pivotal role of patent data in overcoming the data
challenges faced by generative AI models in drug discovery, particularly for
biologics. Watch now.
Join our webinar to explore strategies, best practices, and the evolving
landscape of QARA in today’s dynamic market.
This discussion features DEIB leaders from California Life Sciences,
MassBio, Eli Lilly and Takeda. We explore changing attitudes in the life
sciences workforce, if organizations are adjusting either their DEIB or
communication strategies, and how evolving philosophies around DEIB are
impacting human resources and talent acquisition activities.
Join us in this discussion on how you can optimize your chances of landing a
new role despite a highly competitive job market.